Order Article Reprints

Soria-Chacartegui P, Zubiaur P, Ochoa D, Villapalos-García G, Román M, Matas M, Figueiredo-Tor L, Mejía-Abril G, Calleja S, de Miguel A, et al. Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics. 2023; 15(2):404. https://doi.org/10.3390/pharmaceutics15020404

Soria-Chacartegui, Paula, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina Mejía-Abril, Sofía Calleja, Alejandro de Miguel, and et al. 2023. "Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety" Pharmaceutics 15, no. 2: 404. https://doi.org/10.3390/pharmaceutics15020404

Soria-Chacartegui, P., Zubiaur, P., Ochoa, D., Villapalos-García, G., Román, M., Matas, M., Figueiredo-Tor, L., Mejía-Abril, G., Calleja, S., de Miguel, A., Navares-Gómez, M., Martín-Vilchez, S., & Abad-Santos, F. (2023). Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics, 15(2), 404. https://doi.org/10.3390/pharmaceutics15020404